Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer

Featuring a roundtable discussion on the current and future role of PARP inhibitor-based therapy in the management of prostate cancer, with Drs Neeraj Agarwal, Emmanuel Antonarakis, Susan Slovin, and Prof Karim Fizazi, moderated by Dr Neil Love.

Episode metadata supplied by the publisher feed · Published Aug 14, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer

0:00 2:48:58

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Prostate Cancer Update?

This episode is 2 hours and 48 minutes long.

When was this Prostate Cancer Update episode published?

This episode was published on August 14, 2023.

Can I download this Prostate Cancer Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!